ConvaTec Group PLC (LON:CTEC) Insider Sells £338,567.68 in Stock

ConvaTec Group PLC (LON:CTECGet Free Report) insider Karim Bitar sold 132,253 shares of the firm’s stock in a transaction dated Friday, March 14th. The stock was sold at an average price of GBX 256 ($3.32), for a total value of £338,567.68 ($439,014.11).

Karim Bitar also recently made the following trade(s):

  • On Monday, March 17th, Karim Bitar sold 436,692 shares of ConvaTec Group stock. The stock was sold at an average price of GBX 256 ($3.32), for a total value of £1,117,931.52 ($1,449,600.00).

ConvaTec Group Stock Performance

LON CTEC opened at GBX 258.17 ($3.35) on Friday. The firm has a market capitalization of £6.57 billion, a P/E ratio of 43.48, a P/E/G ratio of 0.93 and a beta of 0.64. ConvaTec Group PLC has a 1-year low of GBX 211.80 ($2.75) and a 1-year high of GBX 295.20 ($3.83). The company has a debt-to-equity ratio of 85.32, a current ratio of 2.26 and a quick ratio of 0.96. The business’s 50-day simple moving average is GBX 247.69 and its 200-day simple moving average is GBX 234.80.

ConvaTec Group Increases Dividend

The company also recently disclosed a dividend, which will be paid on Thursday, May 29th. Stockholders of record on Thursday, April 17th will be paid a $0.05 dividend. This is a positive change from ConvaTec Group’s previous dividend of $0.02. This represents a dividend yield of 1.36%. The ex-dividend date of this dividend is Thursday, April 17th. ConvaTec Group’s payout ratio is currently 84.20%.

Wall Street Analysts Forecast Growth

Separately, Berenberg Bank reissued a “buy” rating and issued a GBX 310 ($4.02) price target on shares of ConvaTec Group in a research note on Wednesday, March 5th.

Check Out Our Latest Research Report on CTEC

ConvaTec Group Company Profile

(Get Free Report)

ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns.

Featured Articles

Receive News & Ratings for ConvaTec Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ConvaTec Group and related companies with MarketBeat.com's FREE daily email newsletter.